Advanced Search

Respiratory Pharmacology Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Ian Hall

    Ian Hall

    Department of Therapeutics and Molecular Medicine, University Hospital of Nottingham, Nottingham, UK

  • Photo of Margaret MacLean

    Margaret MacLean

    Faculty of Biomedical and Life Science, University of Glasgow, Glasgow, Scotland, UK

  • No photo

    Donald Massaro

    Lung Regeneration Lab/Medicine, Georgetown University School of Medicine, Washington, DC, USA

Section Topics

  • » Altitude
  • » COPD
  • » Clinical pulmonary immunopharmacology (Including asthma)
  • » General respiratory pharmacology
  • » Interstitial lung disease
  • » Lung cancer
  • » Neonatal respiratory physiology
  • » Pulmonary hypertension
  • » Respiratory physiology

LATEST EVALUATION

Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia continues to be associated with a significant morbidity and mortality. Prior to this study, two prospective, double-blind, randomized controlled trials concluded that linezolid was statistically noninferior to vancomycin 1g twice...

Paul Pham and Matthew Jones, Johns Hopkins University School of Medicine, USA. F1000 Pharmacology & Drug Discovery

6 Recommended

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

7
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

Wunderink RG, Niederman MS, Kollef MH, Shorr AF, ..., Baruch A, McGee WT, Reisman A, Chastre J. Clin Infect Dis. 2012 Mar 1; 54(5):621-9

2 Evaluations, most recent by

Paul Pham and Matthew Jones, Johns Hopkins University School of Medicine, USA. F1000 Pharmacology & Drug Discovery

  • New Finding
  • Clinical Trial

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000